Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
03/2003
03/19/2003EP1293209A1 Oral pharmaceutical dosage forms with reduced potential for drug abuse
03/19/2003EP1293205A1 Valproic acid and derivatives thereof for the combination therapy of human cancers, for the treatment of tumour metastasis and minimal residual disease
03/19/2003EP1293195A1 Oral pharmaceutical dosage forms with reduced potential for drug abuse, comprising respiratory irritants or bitter substances
03/19/2003EP1293193A1 Use of pantetheine sulfonic acid and/or salts thereof as anti-radical agent
03/19/2003EP1293131A1 Throat care agents
03/19/2003EP1292712A1 Means and methods for monitoring antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids
03/19/2003EP1292709A1 Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
03/19/2003EP1292694A2 A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses
03/19/2003EP1292685A2 Human lyases
03/19/2003EP1292684A2 Proteases
03/19/2003EP1292683A2 Secreted redox proteins
03/19/2003EP1292678A2 G-protein coupled receptors
03/19/2003EP1292676A1 Mutation associated with epilepsy
03/19/2003EP1292675A2 Method of diagnosing, monitoring, staging, imaging and treating colon cancer
03/19/2003EP1292668A2 Gene disruption methodologies in fungi for drug target discovery
03/19/2003EP1292610A1 Methods for treating and preventing alopecia
03/19/2003EP1292601A2 Naaladase inhibitors for treating retinal disorders and glaucoma
03/19/2003EP1292591A2 Substituted bicyclic derivatives for the treatment of abnormal cell growth
03/19/2003EP1292579A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
03/19/2003EP1292568A2 Benzamide ligands for the thyroid receptor
03/19/2003EP1292363A2 Carboxyalkylether-acat inhibitor combinations
03/19/2003EP1292336A2 Conjugates of aminodrugs comprising an oxime bond
03/19/2003EP1292335A2 Combinations and compositions which interfere with vegf/vegf and angiopoietin/tie receptor function and their use (ii)
03/19/2003EP1292325A1 Matrix protein compositions for dentin regeneration
03/19/2003EP1292324A2 Critical illness neuropathy
03/19/2003EP1292323A1 Inhibition of smad3 to prevent fibrosis and improve wound healing
03/19/2003EP1292320A2 Extracts from spermatophyte plants with immunomodulating activity
03/19/2003EP1292316A1 Hemostatic compositions of polyacids and polyalkylene oxides and methods for their use
03/19/2003EP1292313A2 Methods for treating hepatitis delta virus infection with beta-l-2' deoxy-nucleosides
03/19/2003EP1292311A2 Combination therapy for the treatment of depression comprising an antidepressant and an ampa receptor potentiator
03/19/2003EP1292307A2 Method of treating pain using nalbuphine and opioid antagonists
03/19/2003EP1292302A2 Method of treating cardiovascular disease using rapamycin
03/19/2003EP1292301A1 Treatment and prevention of cardiac insulin resistance associated conditions
03/19/2003EP1292300A1 Combinations od dipeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment fo diabete mellitus
03/19/2003EP1292294A1 Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism
03/19/2003EP1292290A2 Pharmaceutical compositions comprising acryloyl distamycin derivatives and topoisomerase i and ii inhibitors
03/19/2003EP1292288A2 2-arachidonylglycerol (2-ag) - an inhibitor of tumor necrosis factor -alfa and neuroprotector of brain in closed head injury
03/19/2003EP1292279A1 The use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
03/19/2003EP1292277A1 Method for protecting human skin
03/19/2003EP1292186A1 Animal and cell models for type ii diabetes and their use
03/19/2003EP1051655A4 Methods and apparatus for accelerated orthokeratology
03/19/2003EP1037637B1 Use of 5ht1a receptor antagonists for preventing and/or treating temporal lobe epilepsy
03/19/2003EP1011686A4 Modulation of human mast cell activation
03/19/2003EP0964697B1 Therapeutic applications of antigens or epitopes associated with impaired cellular peptide processing, e.g. expressed on rma-s cells transfected with a b7-1 gene
03/19/2003EP0964678B1 Use of comt inhibitors for the manufacture of a medicament for the prevention of diabetic vascular dysfunctions
03/19/2003EP0876482B1 Il-13 receptor polypeptide
03/19/2003EP0758245B1 Use of spiramycin for treating gastrointestinal disorders caused by h. pylori
03/19/2003EP0725789B1 Method of obtaining immunoglobulins from colostrum and their use in pharmaceutical composition
03/19/2003EP0704199B1 Transfusion container, transfusion preparation, and comprehensive vitamin-containing high-calorie transfusion preparation
03/19/2003CN1404487A High purity lipopeptides, lipopeptide micelles, process for preparing same
03/19/2003CN1404483A New AZa-indolyl derivatives
03/19/2003CN1404481A Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes
03/19/2003CN1404480A Pyrimidine carboxamides useful as inhibitors of PDE4 isozymes
03/19/2003CN1404473A Substituted 8,8a-dihydro-3aH-indeno [1,2-D] thiazoles, a method for their production and their use as medicaments
03/19/2003CN1404468A Novel use of phenylheteroalkylamine derivatives
03/19/2003CN1404400A Use of IL-18 inhibitors
03/19/2003CN1404394A Pharmaceutical compositions containing steroidal structures and uses thereof
03/19/2003CN1404392A Antiviral azaindole derivatives
03/19/2003CN1404391A Treating allergic and inflammatory conditions
03/19/2003CN1404364A Water containing soluble fiber
03/19/2003CN1403157A Method for treating female sexual dysfunction and evaluating compound for treating female sexual dysfunction
03/19/2003CN1103221C Medicine for treating HIV infections
03/18/2003US6534642 Isolated nucleic acid of given sequence encoding a protein; dysfunction of the human protein implicated in hyper/hypocalcemia, bone disorders, leukemia and cancer
03/18/2003US6534641 Genes which are differentially expressed in cardiovascular disease states, relative to their expression in normal, or non-cardiovascular disease states, and/or in response to manipulations relevant to cardiovascular disease.
03/18/2003US6534548 Isoprenoid compositions for the inhibition of exoprotein production from gram positive bacteria
03/18/2003US6534544 Methods of treatment with compounds having RARα receptor specific or selective activity
03/18/2003US6534543 Oxa acids and related compounds for treating skin conditions
03/18/2003US6534540 Combination and method of treatment of cancer utilizing a COX-2 inhibitor and a 3-hydroxy-3-methylglutaryl-coenzyme-a (HMG-CoA) reductase inhibitor
03/18/2003US6534539 Pharmaceutical composition and method for treatment of dyspepsia
03/18/2003US6534505 Therapeutic polymorphs of a GABA-A alpha-5 inverse agonist and pamoate formulations of the same
03/18/2003US6534489 Organophosphorus compounds and the use thereof
03/18/2003US6534476 Smad6 and uses thereof
03/18/2003US6534299 Peptide for use in development of human diagnostics and therapeutics; for use in deection and treatment of cancer, inflammation, immune disorders and development defects
03/18/2003US6534289 Recombinant nucleic acid encoding receptor having amino acid sequences of extracellular domain of G-protein coupled calcium receptor, seven-transmembrane and intracellular cytoplasmic tail domains of group I metabotropic glutamate receptor
03/18/2003US6534275 Isolated polypeptide having specified amino acid sequence or immunogenic fragment thereof
03/18/2003US6534088 Fibrate-statin combinations with reduced fed-fasted effects
03/18/2003US6534087 Process for preparing a pharmaceutical composition
03/18/2003US6534081 Administration of microparticles in a form suitable for injection and containing active agents suitable for treating or diagonising a disease or painful condition in joints in a patient in need, safe and effective procedure; sustained
03/18/2003US6534061 Isolated DNA98853 and DNA101848 polypeptides
03/18/2003US6534056 Therapeutic and diagnostic uses of protein tyrosine phosphatase TC-PTP
03/18/2003US6534048 Aqueous gel in unit dose form for topical delivery
03/18/2003US6534036 Biological materials and methods useful in the diagnosis and treatment of diseases
03/18/2003US6533767 Methods for enhancing fluid flow through an obstructed vascular site, and systems and kits for use in practicing the same
03/18/2003CA2360311C Improved dialysis solutions and methods
03/18/2003CA2216417C Controlled release of miotic and mydriatic drugs in the anterior chamber
03/18/2003CA2176840C Combination of an antimicrobial compound with a glycerol monoalkylether
03/14/2003WO2002022586A1 Indazoles having an action similar to that of a thyroid hormone, method for the production thereof, and their use in medicaments
03/14/2003CA2422353A1 Indazoles having an action similar to that of a thyroid hormone, method for the production thereof, and their use in medicaments
03/13/2003WO2004043335A2 Methods of treating infection by drug resistant bacteria
03/13/2003WO2003021225A2 Method for classification of anti-psychotic drugs
03/13/2003WO2003020962A2 Method of identifying glycosyl transferase binding compounds
03/13/2003WO2003020949A2 Targeted nucleic acid constructs and uses related thereto
03/13/2003WO2003020947A2 Mid 9002, a human sulfatase family member and uses therefor
03/13/2003WO2003020930A1 IDENTIFICATION AND USE OF MAMMALIAN p21 INHIBITORS
03/13/2003WO2003020892A2 Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY
03/13/2003WO2003020768A1 A method for the treatment or prevention of bone erosion
03/13/2003WO2003020762A1 Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions
03/13/2003WO2003020759A2 A caspase- 8 binding protein, its preparation and use
03/13/2003WO2003020724A1 Polycyclic guanine phosphodiesterase v inhibitors
03/13/2003WO2003020716A1 Piperidine derivatives useful as ccr5 antagonists
1 ... 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 ... 1151